266 related articles for article (PubMed ID: 12432910)
1. Phospholipase A2 receptor: a regulator of biological functions of secretory phospholipase A2.
Hanasaki K; Arita H
Prostaglandins Other Lipid Mediat; 2002 Aug; 68-69():71-82. PubMed ID: 12432910
[TBL] [Abstract][Full Text] [Related]
2. Mammalian phospholipase A2: phospholipase A2 receptor.
Hanasaki K
Biol Pharm Bull; 2004 Aug; 27(8):1165-7. PubMed ID: 15305014
[TBL] [Abstract][Full Text] [Related]
3. [Functional analysis of phospholipase A2 receptor by gene knockout studies].
Yokota Y
Yakugaku Zasshi; 2001 Jan; 121(1):23-33. PubMed ID: 11201160
[TBL] [Abstract][Full Text] [Related]
4. Mouse group X secretory phospholipase A2 induces a potent release of arachidonic acid from spleen cells and acts as a ligand for the phospholipase A2 receptor.
Morioka Y; Saiga A; Yokota Y; Suzuki N; Ikeda M; Ono T; Nakano K; Fujii N; Ishizaki J; Arita H; Hanasaki K
Arch Biochem Biophys; 2000 Sep; 381(1):31-42. PubMed ID: 11019817
[TBL] [Abstract][Full Text] [Related]
5. Suppression of murine endotoxic shock by sPLA2 inhibitor, indoxam, through group IIA sPLA2-independent mechanisms.
Yokota Y; Hanasaki K; Ono T; Nakazato H; Kobayashi T; Arita H
Biochim Biophys Acta; 1999 May; 1438(2):213-22. PubMed ID: 10320804
[TBL] [Abstract][Full Text] [Related]
6. Secretory low-molecular-weight phospholipases A2 and their specific receptor in bile ducts of patients with intrahepatic calculi: factors of chronic proliferative cholangitis.
Shoda J; Kano M; Asano T; Irimura T; Ueda T; Iwasaki R; Furukawa M; Kamiya J; Nimura Y; Todoroki T; Matsuzaki Y; Tanaka N
Hepatology; 1999 Apr; 29(4):1026-36. PubMed ID: 10094942
[TBL] [Abstract][Full Text] [Related]
7. Deficiency of phospholipase A2 receptor exacerbates ovalbumin-induced lung inflammation.
Tamaru S; Mishina H; Watanabe Y; Watanabe K; Fujioka D; Takahashi S; Suzuki K; Nakamura T; Obata JE; Kawabata K; Yokota Y; Murakami M; Hanasaki K; Kugiyama K
J Immunol; 2013 Aug; 191(3):1021-8. PubMed ID: 23817419
[TBL] [Abstract][Full Text] [Related]
8. Deficiency of Phospholipase A
Kishi H; Yamaguchi K; Watanabe K; Nakamura K; Fujioka D; Kugiyama K
Inflammation; 2020 Jun; 43(3):1097-1109. PubMed ID: 32016628
[TBL] [Abstract][Full Text] [Related]
9. Both group IB and group IIA secreted phospholipases A2 are natural ligands of the mouse 180-kDa M-type receptor.
Cupillard L; Mulherkar R; Gomez N; Kadam S; Valentin E; Lazdunski M; Lambeau G
J Biol Chem; 1999 Mar; 274(11):7043-51. PubMed ID: 10066760
[TBL] [Abstract][Full Text] [Related]
10. Secretory phospholipase A2 receptor-mediated activation of cytosolic phospholipase A2 in murine bone marrow-derived mast cells.
Fonteh AN; Atsumi G; LaPorte T; Chilton FH
J Immunol; 2000 Sep; 165(5):2773-82. PubMed ID: 10946309
[TBL] [Abstract][Full Text] [Related]
11. sPLA2 IB induces human podocyte apoptosis via the M-type phospholipase A2 receptor.
Pan Y; Wan J; Liu Y; Yang Q; Liang W; Singhal PC; Saleem MA; Ding G
Sci Rep; 2014 Oct; 4():6660. PubMed ID: 25335547
[TBL] [Abstract][Full Text] [Related]
12. Multifunctional activity of the extracellular domain of the M-type (180 kDa) membrane receptor for secretory phospholipases A2.
Ancian P; Lambeau G; Lazdunski M
Biochemistry; 1995 Oct; 34(40):13146-51. PubMed ID: 7548076
[TBL] [Abstract][Full Text] [Related]
13. Lack of phospholipase A2 receptor increases susceptibility to cardiac rupture after myocardial infarction.
Mishina H; Watanabe K; Tamaru S; Watanabe Y; Fujioka D; Takahashi S; Suzuki K; Nakamura T; Obata JE; Kawabata K; Yokota Y; Inoue O; Murakami M; Hanasaki K; Kugiyama K
Circ Res; 2014 Jan; 114(3):493-504. PubMed ID: 24305469
[TBL] [Abstract][Full Text] [Related]
14. Structural elements of secretory phospholipases A2 involved in the binding to M-type receptors.
Lambeau G; Ancian P; Nicolas JP; Beiboer SH; Moinier D; Verheij H; Lazdunski M
J Biol Chem; 1995 Mar; 270(10):5534-40. PubMed ID: 7890672
[TBL] [Abstract][Full Text] [Related]
15. Receptors for a growing family of secreted phospholipases A2.
Lambeau G; Lazdunski M
Trends Pharmacol Sci; 1999 Apr; 20(4):162-70. PubMed ID: 10322502
[TBL] [Abstract][Full Text] [Related]
16. Potentiation of tumor necrosis factor alpha-induced secreted phospholipase A2 (sPLA2)-IIA expression in mesangial cells by an autocrine loop involving sPLA2 and peroxisome proliferator-activated receptor alpha activation.
Beck S; Lambeau G; Scholz-Pedretti K; Gelb MH; Janssen MJ; Edwards SH; Wilton DC; Pfeilschifter J; Kaszkin M
J Biol Chem; 2003 Aug; 278(32):29799-812. PubMed ID: 12782627
[TBL] [Abstract][Full Text] [Related]
17. Recombinant production and properties of binding of the full set of mouse secreted phospholipases A2 to the mouse M-type receptor.
Rouault M; Le Calvez C; Boilard E; Surrel F; Singer A; Ghomashchi F; Bezzine S; Scarzello S; Bollinger J; Gelb MH; Lambeau G
Biochemistry; 2007 Feb; 46(6):1647-62. PubMed ID: 17279628
[TBL] [Abstract][Full Text] [Related]
18. Identification of a soluble form phospholipase A2 receptor as a circulating endogenous inhibitor for secretory phospholipase A2.
Higashino Ki K; Yokota Y; Ono T; Kamitani S; Arita H; Hanasaki K
J Biol Chem; 2002 Apr; 277(16):13583-8. PubMed ID: 11830583
[TBL] [Abstract][Full Text] [Related]
19. [Mechanism of podocyte pyroptosis aggravated by up-regulation of phospholipase A
Feng MX; An Q; Yu YN; Chen YQ; Yang XQ; Li BS; Jiang W
Zhonghua Yi Xue Za Zhi; 2023 Jun; 103(22):1714-1723. PubMed ID: 37302862
[No Abstract] [Full Text] [Related]
20. sPLA2-IB and PLA2R mediate insufficient autophagy and contribute to podocyte injury in idiopathic membranous nephropathy by activation of the p38MAPK/mTOR/ULK1
Yang L; Wu Y; Lin S; Dai B; Chen H; Tao X; Li G; Wan J; Pan Y
FASEB J; 2021 Feb; 35(2):e21170. PubMed ID: 33184968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
